AZGP1, alpha-2-glycoprotein 1, zinc-binding, 563

N. diseases: 101; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006625
Disease: Cachexia
Cachexia
0.050 Biomarker phenotype BEFREE By showing that ZAG binds fatty acids in different locations, we demonstrate an augmented mechanism for fatty acid binding in ZAG that is distinct from other known fatty acid binding proteins, and may be relevant to cachexia. 31506272 2019
CUI: C0006625
Disease: Cachexia
Cachexia
0.050 Biomarker phenotype BEFREE ZAG may play an important role, probably as an autocrine/paracrine modulator of adipose mass in cachexia. 23448999 2013
CUI: C0006625
Disease: Cachexia
Cachexia
0.050 AlteredExpression phenotype BEFREE Although the exact role of ZAG in adipose tissue remains to be clarified, there is evidence that ZAG expression appears to be inversely related to adiposity, being upregulated in cachexia whereas reduced in obesity. 20514048 2010
CUI: C0006625
Disease: Cachexia
Cachexia
0.050 Biomarker phenotype BEFREE As a candidate gene we further evaluated the expression of alpha(2)-zinc-glycoprotein 1 (AZGP1), a soluble protein that stimulates lipolysis, induces a reduction in body fat in mice, is associated with the cachexia related to cancer, and is known to be expressed in secretory cells of lung epithelium. 19188554 2009
CUI: C0006625
Disease: Cachexia
Cachexia
0.050 Biomarker phenotype BEFREE Zinc-alpha(2)-glycoprotein (ZAG), the sole soluble member of this superfamily has been implicated in cachexia, a poorly understood yet life-threatening, severe wasting syndrome. 17234189 2007